Literature DB >> 28196979

Acremopeptin, a new peptaibol from Acremonium sp. PF1450.

Masatomi Iijima1, Masahide Amemiya2, Ryuichi Sawa2, Yumiko Kubota2, Takao Kunisada3, Isao Momose1, Manabu Kawada1, Masakatsu Shibasaki2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28196979     DOI： 10.1038/ja.2017.15

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  13 in total

1.  Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo.

Authors:  Adonia E Papathanassiu; Nicholas J MacDonald; David R Emlet; Hong A Vu
Journal:  Cell Stress Chaperones       Date:  2010-10-07       Impact factor: 3.667

Review 2.  Pulling the plug on a cancer cell by eliminating XIAP with AEG35156.

Authors:  Eric C LaCasse
Journal:  Cancer Lett       Date:  2012-07-07       Impact factor: 8.679

3.  F1F0-ATP synthase functions as a co-chaperone of Hsp90-substrate protein complexes.

Authors:  Adonia E Papathanassiu; Nicholas J MacDonald; Akos Bencsura; Hong A Vu
Journal:  Biochem Biophys Res Commun       Date:  2006-05-02       Impact factor: 3.575

4.  Aib and iva in the biosphere: neither rare nor necessarily extraterrestrial.

Authors:  Hans Brückner; Dieter Becker; Walter Gams; Thomas Degenkolb
Journal:  Chem Biodivers       Date:  2009-01       Impact factor: 2.408

5.  Studies on peptide antibiotics, leucinostatins. I. Separation, physico-chemical properties and biological activities of leucinostatins A and B.

Authors:  K Fukushima; T Arai; Y Mori; M Tsuboi; M Suzuki
Journal:  J Antibiot (Tokyo)       Date:  1983-12       Impact factor: 2.649

6.  The structure of bovine F1-ATPase complexed with the peptide antibiotic efrapeptin.

Authors:  J P Abrahams; S K Buchanan; M J Van Raaij; I M Fearnley; A G Leslie; J E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

7.  Regulation of survivin function by Hsp90.

Authors:  Paola Fortugno; Elena Beltrami; Janet Plescia; Jason Fontana; Deepti Pradhan; Pier Carlo Marchisio; William C Sessa; Dario C Altieri
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

Review 8.  IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.

Authors:  Mads Gyrd-Hansen; Pascal Meier
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

9.  Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin.

Authors:  Naoto Nakamura; Tomohiro Yamauchi; Masashi Hiramoto; Masatoshi Yuri; Masanori Naito; Masahiro Takeuchi; Kentaro Yamanaka; Aya Kita; Takahito Nakahara; Isao Kinoyama; Akira Matsuhisa; Naoki Kaneko; Hiroshi Koutoku; Masao Sasamata; Hiroyuki Yokota; Shigeki Kawabata; Kiyoshi Furuichi
Journal:  Mol Cell Proteomics       Date:  2012-03-22       Impact factor: 7.381

10.  YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

Authors:  Takahito Nakahara; Aya Kita; Kentaro Yamanaka; Masamichi Mori; Nobuaki Amino; Masahiro Takeuchi; Fumiko Tominaga; Shinji Hatakeyama; Isao Kinoyama; Akira Matsuhisa; Masafumi Kudoh; Masao Sasamata
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 13.312
View more
  1 in total

1.  Rare Glutamic Acid Methyl Ester Peptaibols from Sepedonium ampullosporum Damon KSH 534 Exhibit Promising Antifungal and Anticancer Activity.

Authors:  Yen T H Lam; Manuel G Ricardo; Robert Rennert; Andrej Frolov; Andrea Porzel; Wolfgang Brandt; Pauline Stark; Bernhard Westermann; Norbert Arnold
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.